| Literature DB >> 27551180 |
Sevket Arslan1, Ramazan Ucar1, Ahmet Zafer Caliskaner1.
Abstract
Metamizole, a non-steroidal anti-inflammatory drug with weak anti-inflammatory and spasmolytic effects, is used as an analgesic and antipyretic agent. Many adverse reactions to metamizole, such as early or late-onset systemic reactions and bone marrow suppression, have been identified. In this report, we present a case of systemic reaction after the application of parenteral metamizole (Novalgin(®) ampoule; Sanofi Aventis, İstanbul, Turkey) and discuss the mechanism underlying the reaction.Entities:
Keywords: Abdominal pain; metamizole; systemic reactions
Year: 2016 PMID: 27551180 PMCID: PMC4970554 DOI: 10.5152/eurasianjmed.2015.0024
Source DB: PubMed Journal: Eurasian J Med ISSN: 1308-8734